{
  "name" : "twin.sci-hub.se_5835_f9d24bc09eb6b89500d491395693af1f_liu2016.pdf",
  "metadata" : {
    "source" : "CRF",
    "title" : "Photosensitizer Cross-linked Nano-Micelle Platform for Multimodal Imaging Guided Synergistic Photothermal/Photodynamic Therapy†",
    "authors" : [ "Xiaodong Liu", "‡a", "Guangbao Yang", "‡b", "Lifen Zhang", "Zhuang Liu", "*b", "Zhenping Cheng*a", "Xiulin Zhua" ],
    "emails" : [ ],
    "sections" : [ {
      "heading" : null,
      "text" : "This is an Accepted Manuscript, which has been through the Royal Society of Chemistry peer review process and has been accepted for publication.\nAccepted Manuscripts are published online shortly after acceptance, before technical editing, formatting and proof reading. Using this free service, authors can make their results available to the community, in citable form, before we publish the edited article. We will replace this Accepted Manuscript with the edited and formatted Advance Article as soon as it is available.\nYou can find more information about Accepted Manuscripts in the Information for Authors.\nPlease note that technical editing may introduce minor changes to the text and/or graphics, which may alter content. The journal’s standard Terms & Conditions and the Ethical guidelines still apply. In no event shall the Royal Society of Chemistry be held responsible for any errors or omissions in this Accepted Manuscript or any consequences arising from the use of any information it contains.\nAccepted Manuscript\nNanoscale\nwww.rsc.org/nanoscale\nView Article Online View Journal\nThis article can be cited before page numbers have been issued, to do this please use: X. Liu, G. Yang, L.\nZhang, Z. Liu, Z. Cheng and X. Zhu, Nanoscale, 2016, DOI: 10.1039/C6NR04835H.\nJournal Name RSCPublishing\nARTICLE \nThis journal is © The Royal Society of Chemistry 2014  J. Name., 2014, 00, 1‐3 | 1 \nCite this: DOI: 10.1039/x0xx00000x\nReceived 00th January 2014, Accepted 00th January 2014\nDOI: 10.1039/x0xx00000x\nwww.rsc.org/\nPhotosensitizer Cross-linked Nano-Micelle Platform for Multimodal Imaging Guided Synergistic Photothermal/Photodynamic Therapy† Xiaodong Liu,‡a Guangbao Yang,‡b Lifen Zhang,a Zhuang Liu,*b Zhenping Cheng*a and Xiulin Zhua\nThe multifunctional nano-micelle platform holds great promise to enhance the accuracy and efficiency of cancer diagnosis and therapy. In this work, an amphiphilic poly[(poly(ethylene glycol) methyl ether methacrylate)-co-(3-aminopropyl methacrylate)]-block-poly(methyl methacrylate) (P(PEGMA-co-APMA)-b-PMMA) block copolymer was synthesized by successive RAFT polymerizations and subsequent chemical modification. Then the multifunctional micelles with high solubility in physiological environments were developed by the self-assembly and crosslinking processes. The photosensitizer segment, 5,10,15,20-tetrakis (4-carboxyphenyl) porphyrin (TCPP), serves as the tetra-functional cross-linker, photodynamic agent, fluorescence indicator, as well as magnetic resonance (MR) contrast agent after labelling with manganese ions (Mn2+), while IR825 simultaneously locating in the interior of fabricated micelles contributed to the photoacoustic (PA) imaging ability and the photothermal effect. The prepared nanoparticles show great stability in physiological environmental with uniform morphology and diameters at around 80 nm as disclosed by stability investigation, TEM and DLS analysis. IR825@P(PEGMA-co-APMA)-b-PMMA@TCPP/Mn nanoparticles displayed high in vivo tumor uptake with a long blood circulation half-life (~3.64 h) by the EPR effect after intravenous (i.v.) injection as revealed by fluorescence, MR and PA imaging models. In vivo anti-tumor effects were achieved via the combined photothermal and photodynamic therapy without noticeable dark toxicity, and this strategy was able to induce a remarkably improved synergistic therapeutic effect to both superficial and deep regions of tumors under mild conditions compared with either single photothermal or photodynamic mechanism."
    }, {
      "heading" : "Introduction",
      "text" : "Polymeric micelles have been highly attractive in biological and medical applications. As nanoparticle carriers in contrast to free molecules, their advantageous characteristics lies in their tunable properties, low toxicity, high hydrophobic molecule loading capacity, high water solubility, better biocompatibility, high structural stability, prolonged blood circulation and enhanced accumulation in diseased tissues within a therapeutic window.1-9 Amphiphilic block copolymer micelles with spherical and nanosized structures (10-100 nm) are watersoluble and biocompatible core-shell nanocarriers, and have been frequently employed to encapsulate, stabilize and deliver potential therapeutic agents to solid tumors due to the enhanced permeability and retention (EPR) effect.10-13 The hydrophilic outer shell of micelles can prevent protein adsorption and prolong the blood circulation time, while the hydrophobic core serves as a container for drug loading and protects them from elimination in blood circulation.14 Stabilization of micelles by crosslinking can prevent disassembly of micelles into single amphiphilic molecules,15-17 which greatly enhance the cellular uptake, strengthen the structural integrity, shield the functional a Suzhou key Laboratory of Macromolecular Design and Precision Synthesis, Jiangsu Key Laboratory of Advanced Functional Polymer Design and Application, Department of Polymer Science and Engineering, College of Chemistry, Chemical Engineering and Materials Science, Soochow University, Suzhou 215123, China. Fax: +86-512- 65882787, E-mail: chengzhenping@suda.edu.cn (Z. P. Cheng) b Institute of Functional Nano and Soft Materials (FUNSOM) and Jiangsu Key Laboratory for Carbon-Based Functional Materials and Devices, Soochow University, Suzhou 215123, China. E-mail: zliu@suda.edu.cn (Z. Liu) † Electronic Supplementary Information (ESI) available: [GPC, Fluorescence emission, 1H NMR, 13C NMR, HRMS and data]. See DOI: 10.1039/b000000x/ ‡Xiaodong Liu and Guangbao Yang contributed equally to this work.\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n2 8\nJu ly\n2 01\n6. D\now nl\noa de\nd by\nC or\nne ll\nU ni\nve rs\nity L\nib ra\nry o\nn 28\n/0 7/\n20 16\n1 1:\n26 :1\n9.\nView Article Online DOI: 10.1039/C6NR04835H\nARTICLE  Journal Name \n2 | J.  Name., 2014, 00, 1‐3  This journal is © The Royal Society of Chemistry 2014 \nagents against protein deactivation, as well as prolong the in vivo circulation time.18-22 The use of shell crosslinked micelles (so-called knedels), among various pathways to stabilize these self-aggregates, was proved to be a facial approach without affecting the loading and release behaviors of therapeutic agents in the core.23 Recent years have witnessed the emergence of various controlled and “living” free radical polymerization (CLRP) methods providing convenient conditions for constructing various structures of polymers.24-27 As an important member of the CLRP family, reversible addition-fragmentation chain transfer radical (RAFT) polymerization is a valid synthetic method to prepare amphiphilic polymers with well-defined architectures, predictable composition, and narrow molecular weight distributions.28, 29 Of particular importance is that RAFT polymerization has been observed to be a robust synthetic technique suitable for careful tailoring of the hydrophobic and hydrophilic blocks with functional groups to fabricate polymeric micelles for biological applications.\nThe traditional anticancer therapies, including chemotherapy, surgery resection, aggressive surgery and ionizing radiotherapy, usually suffers from drug resistance, potential drug-induced mutations, toxic side effects and inevitably induce lesions on irradiated tissues, which usually lead to incomplete tumor ablation. Nowadays, photothermal therapy (PTT) and photodynamic therapy (PDT) are emerging as minimally invasive and highly effective phototherapy techniques for applications in the biological and medical fields due to their unique advantages such as high specificity, minimal invasiveness and high efficiency.30, 31 Photothermal agents, which involves various inorganic32-35 and organic36-38 nanostructures within the tissue-transparent near-infrared (NIR) window (700-900 nm) for PTT cancer treatment, can effectively convert the absorbed NIR laser irradiation energy into heat to ablate subcutaneous tumors.36, 38-41 While PDT is a non-invasive therapeutic approach in which photosensitizers (PSs) could generate cytotoxic reactive oxygen species (ROS), especially cytotoxic singlet oxygen (1O2), for irreversible destruction of diseased cells and tissues upon photoexcitation.42-47 Combination therapy for cancer treatment, which is useful to disturb the cell repair and reproduction cycle in different stages and enhance the apoptosis of cancer cells, may be of great importance to improve the diagnosis accuracy and therapy efficiency to overcome the defect of unique cancer treatment.48-52 Among various types of combination therapies delivered by nanoscale theranostic agents, the combined photothermal and photodynamic therapy has aroused tremendous concern in recent years.53-57 Currently used inorganic nano-materials are usually non-biocompatible and may reside inside tissues for a long period of time upon systemic administration, while organic nanoparticles, typically polymeric micelles and vesicles as PTT or PDT agents, can avoid these defects, and thus attract significant attention currently. The combination of photothermal and photodynamic therapies, based on a polymeric platform by control and “living” radical polymerization to realize synergistic tumor ablation, has not been reported yet to the best of our knowledge.\nIn this work, a simple strategy to synthesis and modify a diblock polymer based theranostic nano-platform (IR825@P(PEGMA-co-APMA)-b-PMMA@TCPP/Mn micelles) with desired tumor targeting ability, multiple imaging and therapy functionalities was developed. The hydrophilic segment of the prepared polymeric micelles was based on the biocompatible PPEGMA shell with the significantly improved encapsulation efficacy of the therapeutic agents by the EPR effect on solid tumors. PMMA was chosen as the hydrophobic block for building up the core of the micelles for the loading of IR825, and this photothermal therapy agent58-60 was thus incorporated into the core of self-assembled IR825@P(PEGMA-co-APMA)-b-PMMA micelles by physical encapsulation with an entrapment capacity of 4.0 wt%. The amine bearing segments derived from BOC protected sections were then used as the crosslinking sites for the conjugation of 5,10,15,20-tetrakis (4-carboxyphenyl) porphyrin (TCPP). In this way, as the photodynamic therapy agent and a crosslinker for the stabilization and functionalization of micelles, TCPP could react with primary amines on the polymer backbone to yield multifunctional crosslinked polymeric micelles with significantly improved stability. Besides, the TCPP bridges also possessed manganese-II (Mn2+) chelating sites promising for T1-weighted magnetic resonance (MR) imaging.\nThe obtained IR825@P(PEGMA-co-APMA)-bPMMA@TCPP/Mn nanoparticles containing both photosensitizer (TCPP) and photothermal (IR825) agents showed great stability in physiological media with the size measured to be ~80 nm by DLS and TEM analysis. The micelles displayed obvious contrast in photoacoustic (PA), MR and fluorescence imaging, revealing efficient tumor uptake of the multi-functional nanoparticles. The micelles also exhibited high singlet oxygen (1O2) generation ability under 660-nm irradiation and high potothermal conversion efficiency exposed to an 808-nm laser. In vivo multimodal imaging-guided photothermal and photodynamic combination therapy was carried out to investigate the tumor ablation effect compared with single therapy models. Combinational co-delivery of photothermal and photodynamic therapy agents within the reported polymeric micelle platform can result in enhanced synergistic effects based on its hyperthermia and photdynamic efficacy. Therefore, the development of our biocompatible polymeric theranostic system with PA, MR and fluorescence imaging abilities, as well as photothermal and photodynamic functions, may be of great promise in cancer diagnose and therapy."
    }, {
      "heading" : "Experimental section",
      "text" : ""
    }, {
      "heading" : "Materials",
      "text" : "Poly(ethylene glycol) methyl ether methacrylate (PEGMA, 98%, Mn = 950 g/mol) was obtained from Aldrich Chemical Company, and was used without further purification. Methyl methacrylate (MMA) was purchased from Shanghai Chemical Reagents and was purified by passing through a column filled with neutral aluminum oxide before use. Triethylamine (TEA) was purchased from Shanghai Chemical Reagent Company. N,N’-azobisisobutyronitrile (AIBN) was purchased from\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n2 8\nJu ly\n2 01\n6. D\now nl\noa de\nd by\nC or\nne ll\nU ni\nve rs\nity L\nib ra\nry o\nn 28\n/0 7/\n20 16\n1 1:\n26 :1\n9.\nView Article Online DOI: 10.1039/C6NR04835H\nJournal Name  ARTICLE \nThis journal is © The Royal Society of Chemistry 2014  J. Name., 2014, 00, 1‐3 | 3 \nShanghai Chemical Reagent Company and used after recrystallization with 95% ethanol. N-(3dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC; Aldrich, 98%), N,N-dimethylformamide (DMF; Aldrich), dichloromethane (DCM; Aldrich) and anhydrous tetrahydrofuran (THF; Aldrich) were used without any further purification. 3-(4-Carboxybenzyl)-1,1,2-trimethyl-1Hbenzo[e]indolium bromide and 2-chloro-1-formyl-3(hydroxymethylene)cyclohex-1-ene were prepared according to the literature reported methods.58, 61 Tert-butyl 3- hydroxypropylcarbamate was synthesized by a reported method.62 2-Cyanoprop-2-yl 1-dithionaphthalate (CPDN) was prepared according to a previously reported method.63, 64 5,10,15,20-tetrakis (4-carboxyphenyl) porphyrin (TCPP) was synthesized according to the previously reported procedure.65 All other chemicals were obtained from Shanghai Chemical Reagents (Shanghai, China) and were used as received unless mentioned. Dialysis tube (molecular weight cut-off: 3500 g mol-1) was purchased from Shanghai Chemical Reagent Company."
    }, {
      "heading" : "Synthesis of IR825",
      "text" : "The compound IR825 was synthesized using a modified method according to the reported procedure.66, 67 Specifically, 3-(4-carboxybenzyl)-1,1,2-trimethyl-1H-benzo[e]indolium bromide (850 mg, 2.0 mmol) and 2-chloro-1-formyl-3(hydroxymethylene)cyclohex-1-ene (173 mg, 1.0 mmol) were dissolved into a mixed solvent of toluene (60 mL) and nbutanol (140 mL) in a Dean-Stark apparatus. The mixture was heated to 120 oC under an argon (Ar) atmosphere and refluxed for 6 h, the solvent was then removed under vacuum. The obtained resultant was washed with ethyl acetate and ether to obtain target dye as a deep green solid (540 mg, yield: 59.7%). Mp: 207-208 oC. IR v (KBr, cm-1): 2932, 1627, 1548, 1506, 1431, 1394, 1357, 1270, 1238, 1141, 1110, 1064, 1011, 917, 897, 823, 673. 1H NMR (300 MHz, DMSO-d6) δ 12.97 (s, 2H), 8.36-8.32 (m, 4H), 8.08-8.05 (m, 4H), 7.96 (t, J = 6.7 Hz, 4H), 7.69 (t, J = 8.5 Hz, 4H), 7.54 (t, J = 7.3 Hz, 2H), 7.44 (t, J = 7.4 Hz, 4H), 6.40 (d, J = 14.3 Hz, 2H), 5.77 (s, 4H), 2.59-2.55 (br, 4H), 2.02 (s, 12H), 1.77 (br, 2H). 13C NMR (75 MHz, DMSOd6) δ 174.56, 167.35, 148.62, 143.02, 140.59, 140.45, 133.97, 132.06, 131.13, 130.75, 130.51, 130.43, 130.33, 128.41, 128.02, 127.54, 127.37, 127.21, 125.69, 122.85, 112.19, 102.40, 60.82, 51.42, 35.15, 27.59, 19.10. HRMS (ESI) m/z: [M - Br]+ calcd for C54H48ClN2O4, 823.3303; found, 823.3322. UV-Vis λmax: 825 nm (MeOH); 834 nm (DMF).\nSynthesis of 3-(tert-butoxycarbonylamino)propyl methacrylate (BAPMA)\nTert-butyl 3-hydroxypropylcarbamate (4.0 g, 22.8 mmol) was dissolved in anhydrous THF (10 mL), and triethylamine (3.20 mL) was added. The reaction mixture was cooled to 0 °C in an ice bath before methacryloyl chloride (2.23 mL, 23.0 mmol) was added dropwise under magnetic stirring. Then the ice bath was removed and the reaction was further left to stir at room temperature overnight. After the reaction, the precipitated solid was filtered off, and the solvent of the filtrate was removed under reduced pressure on a rotary evaporator. The crude\nproduct was subjected to gel column chromatography using chloroform as the eluent. The second fraction as the target product was collected as a clear oil (4.1 g, yield: 73.9%. 1H NMR (300 MHz, CDCl3) δ 6.11 (s, 1H), 5.57 (s, 1H), 4.73 (s, 1H), 4.22 (t, J = 6.1 Hz, 2H), 3.22 (q, J = 6.3 Hz, 2H), 1.95 (s, 3H), 1.92-1.83 (m, 2H), 1.44 (s, 9H). 13C NMR (75 MHz, CDCl3) δ 167.48, 155.91, 136.22, 125.68, 77.22, 62.30, 37.57, 29.12, 28.40, 18.33. HRMS (ESI) m/z: [M + Na]+ calcd for C12H21NNaO4, 266.1368; found 266.1376.\nSynthesis of P(PEGMA-co-BAPMA) (macro-RAFT agent) by RAFT polymerization\nThe macro-RAFT agent P(PEGMA-co-BAPMA) was synthesized by RAFT polymerization of PEGMA and BAPMA using AIBN as the initiator and CPDN as the chain transfer agent. The polymerization procedure with a molar ratio of [PEGMA]0/[BAPMA]0/[CPDN]0/[AIBN]0 = 80/30/1/0.3 was given as follows: PEGMA (1.0 g, 1.053 mmol), BAPMA (96.05 mg, 0.395 mmol), CPDN (3.57 mg, 0.0132 mmol), and AIBN (0.65 mg, 0.00395 mmol) were dissolved in 1.0 mL of freshly distilled DMF in a 5 mL dried ampoule with a magnetic stir bar. The resulting mixture was degassed by three freezeevacuate-thaw cycles, backfilled with dry argon (Ar), and then flame-sealed before being immersed in a preheated oil bath at 80 ◦C. After reaction for 50 h, the conversion of PEGMA and BAPMA was determined to be 85.8% and 91.2% by 1H NMR analysis, respectively. The reaction mixture was further purified by dialysis (molecular weight cut-off: 3500 g mol−1) against distilled (DI) water for 48 h to remove any unreacted monomers. Subsequently, the solvent was removed by freeze drying to obtain the polymer as a pink solid. (Mn,GPC = 53600 g mol−1, Mw/Mn = 1.35; Mn,1H NMR = 70890 g mol−1).\nSynthesis of P(PEGMA-co-BAPMA)-b-PMMA by RAFT polymerization\nP(PEGMA-co-BAPMA) was employed as a macro-RAFT agent for the synthesis of P(PEGMA-co-BAPMA)-b-PMMA. In a 5 mL dried ampoule, MMA (112.8 μL, 1.0638 mmol), P(PEGMA-co-BAPMA) (500 mg, 0.00705 mmol), and AIBN (0.23 mg, 0.0014 mmol) were dissolved in 1.0 mL of freshly distilled DMF to give a molar ratio of [MMA]0/[macroRAFT]0/[AIBN]0 = 150/1/0.2. The ampoule was purged with dry Ar prior to being heated in an oil bath at 80 ◦C. After polymerization for 30 h, the reaction was stopped by placing the ampoule in an ice bath, and the reaction mixture was dissolved in 2 mL of THF and then poured into a large excess of n-hexane to precipitate the resulting product. The polymer was further purified twice by the redissolution/reprecipitation procedure, and finally dried under vacuum overnight to obtain a slight pink solid. Monomer conversion was determined gravimetrically. (Yield: 45.5%; Mn,GPC = 60490 g mol−1, Mw/Mn = 1.36; Mn,1H NMR = 77520 g mol−1).\nDeprotection of P(PEGMA-co-BAPMA)-b-PMMA into P(PEGMA-co-APMA)-b-PMMA\nBy employing tert-butyl dicarbonate for the protection of 3- amino-1-propanol followed by reacting with methacryloyl\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n2 8\nJu ly\n2 01\n6. D\now nl\noa de\nd by\nC or\nne ll\nU ni\nve rs\nity L\nib ra\nry o\nn 28\n/0 7/\n20 16\n1 1:\n26 :1\n9.\nView Article Online DOI: 10.1039/C6NR04835H\nARTICLE  Journal Name \n4 | J.  Name., 2014, 00, 1‐3  This journal is © The Royal Society of Chemistry 2014 \nchloride, the monomer 3-(tert-butoxycarbonylamino)propyl methacrylate (BAPMA) was prepared, and the tert-butyl carbamates can be easily cleaved by an acidic agent such as hydrochloric acid or trifluoroacetic acid. Specifically, P(PEGMA-co-BAPMA)-b-PMMA (200 mg, 0.00258 mmol) and 0.5 mL of trifluoroacetic acid (TFA) were dissolved in 5 mL of DCM. The reaction mixture was left to stir overnight at room temperature. Finally, the polymer was precipitated in nhexane, and the collected polymer was dissolved in DI water. Then the resultant solution was transferred to a dialysis tube (molecular weight cut-off: 3500 g mol−1) to dialyze against water for 24 h with constant water replacement to remove the residual TFA. The successful deprotection of BOC groups was confirmed by the disappearance of the tert-butyl peaks (1.48- 1.50 ppm) in 1H NMR spectrum (Mn,1H NMR = 74850 g mol−1).\nPreparation of IR825 loaded micelles (M1:  IR825@P(PEGMA-co-APMA)-b-PMMA micelles)\nThe dialysis method was implied to load the thermal therapy agent (IR825) into micelles. In a typical experiment procedure, P(PEGMA-co-APMA)-b-PMMA (100 mg) and IR825 (5 mg) were dissolved in DMSO (1.0 mL) and incubated for 30 min, followed by dropwise addition into DI water (12 mL) over a period of 1 h using a springe pump. The prepared polymerIR825 mixture was then dialyzed against DI water using a dialysis tube with a molecular cut off of 3500 g mol−1 for 24 h to remove excess DMSO. By centrifugation at 20000 rpm for 5 minutes, IR825 that was not encapsulated in the micelles was precipitated, and the supernatant was extracted as a transparent dark green solution for further use. The encapsulation percent and efficiency of IR825 were determined by investigating the absorbance intensity based on the concentration-absorption dependent standard curve of IR825. Specifically, 100 µL of the micelle solution (8 mg mL−1) was diluted with 1.9 mL of DMF to give a final test solution. The solution was assayed using a UV spectrophotometer at 834 nm and results were obtained using a standard curve (y = -0.2042 + 195.8655 x). The entrapment efficiency and loading efficiency were calculated by the following formulae: The drug loading content (DLC, wt%) = (amount of drug in micelles)/(amount of drug and polymer in micelles) × 100; drug loading efficiency (DLE, wt%) = (amount of drug in micelles)/(total amount of feeding drug) × 100.\nPreparation of IR825 loaded and Mn2+-TCPP crosslinked micelles (M2:  IR825@P(PEGMA-co-APMA)-bPMMA@TCPP/Mn micelles)\nThe TCPP crosslinked micelles were fabricated by adding 8 mL of Na2HPO4-citric acid buffer solution (pH 8.5, 0.1 M) containing 7.5 mg of TCPP into above prepared uncross-linked IR825 loaded micelle solution (6.5 mL, polymer: 50 mg; IR825: 2.06 mg), and 16 mg of EDC was added for crosslinking. The mixture solution was left to stir for 48 h at room temperature, followed by transferred into a dialysis tube (molecular weight cut-off: 3500 g mol−1) and dialyzed against DI water for 24 h to remove any unreacted EDC and the saline material of buffer solution. As the buffer solution in the dialysis tube was\ngradually exchanged to DI water, the fraction of TCPP that was not involved in the crosslinking of the micelles precipitated out and was removed by centrifugation at 20000 rpm for 5 minutes. The concentration of TCPP conjugated onto micelles were calculated by its standard curve and determined by the characteristic absorbance peak at 414 nm (y = 0.0566 + 219.0774 x). To chelate manganese with TCPP molecules anchored at the polymers, MnCl2.4H2O (4 mg) was added into the micelle solution at a molar ratio of 1.5:1 (nmanganese-II : nTCPP), and stirred in the dark for 24 h. The resultant solution was subjected to dialysis (molecular weight cut-off: 3500 g mol−1) against DI water for 24 h to remove the uncoordinated MnCl2, then the final obtained solution was stored at 4 °C for future use."
    }, {
      "heading" : "Singlet oxygen determination",
      "text" : "Singlet oxygen sensor green (SOSG), was employed here during the detection process. SOSG is highly sensitive to singlet oxygen (1O2), and its quenched fluorescence in the aqueous solution will be recovered in the presence of 1O2. Different samples were mixed with 2.5 μM SOSG, and then irradiated by a 660-nm laser at the power density of 5 mW/cm2 for different periods of time. The generation of singlet oxygen was determined by measuring recovered fluorescence of SOSG under the excitation wavelength of 494 nm. Error bars were based on triplicated samples.\nCell culture and animal models\nMurine breast 4T1 cancer cells were cultured in standard cell media recommended by American type culture collection (ATCC). The cancer cells were cultured in RPMI-1640 cell medium supplemented with 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin at 37 °C in a humidified 5% CO2-containing atmosphere. Balb/c mice were obtained from Nanjing Peng Sheng Biological Technology Co, Ltd and performed under protocols approved by Soochow University Laboratory Animal Center. The 4T1 tumor models were generated by subcutaneous injection of 2×106 cells in 50 mL PBS into female Balb/c mice. The mice were used for treatments when the tumor volume reached 100~150 mm3 after about 6 days.\nConfocal laser scanning microscopy\nTo determine the cellular uptake efficiencies, 4T1 cancer cells with 5×104 density were loaded onto a glass-bottomed coverslip with a diameter of 35 mm and cultured for 48 h for confocal fluorescence imaging. The cells were washed with phosphate buffered saline (PBS, pH 7.4) solution three times before cell staining, and then the cells were incubated with IR825@P(PEGMA-co-APMA)-bPMMA@TCPP/Mn micelles (20 μL, 0.05 mg mL-1 based on TCPP) and the nuclei specific staining compound 4’,6-diamidino-2phenylindole (DAPI) in PBS buffer for different periods of time (1, 2, 4, 8 h). After washing cells with PBS for three times, the cellular fluorescence obtained from TCPP was analyzed by a Leica SP5 laser scanning confocal fluorescence microscope to determine the cellular uptake of micelles. The blue channel for DAPI was excited at 405 nm and its blue emission was collected in the range of 435-480 nm; the red channel for the micelles was excited at 633 nm and its red emission was collected in the range of 650-800 nm. All images were\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n2 8\nJu ly\n2 01\n6. D\now nl\noa de\nd by\nC or\nne ll\nU ni\nve rs\nity L\nib ra\nry o\nn 28\n/0 7/\n20 16\n1 1:\n26 :1\n9.\nView Article Online DOI: 10.1039/C6NR04835H\nJournal Name  ARTICLE \nThis journal is © The Royal Society of Chemistry 2014  J. Name., 2014, 00, 1‐3 | 5 \nobtained using the same settings and processed with attached software.\nMTT assay and cell toxicity assay\nStandard thiazolyl tetrazolium (MTT) assays were performed to evaluate the PTT, PDT and combined therapy effects of as-prepared micelles on the relative viabilities of 4T1 cells. 4T1 cells seeded onto 96-well plates at the density of 1 × 104 cells/well were incubated with various concentrations of IR825@P(PEGMA-co-APMA)-bPMMA@TCPP/Mn micelles for 6 h. Afterwards cells of the PTT group were irradiated by an 808-nm laser at the power density of 0.8 W/cm2 for 5 min, while cells of the PDT group were exposed to the 660-nm light at the power density of 5 mW/cm2 for 60 min. For combination therapy, cells of the PTT+PDT group were processed by PTT (808-nm laser, 0.8 W/cm2, 5 min) and PDT (660-nm light, 5 mW/cm2, 60 min) treatment successively.\nAfter phototherapy processing, the cells were then incubated at 37oC for additional 24 h before the standard MTT test was conducted to determine the cell viabilities relative to untreated control cells. In brief, 3-(4,5-dimethylthiazol-2-y1)-2,5diphenyltetrazolium bromide (MTT, 5 mg mL-1, 10 μL) in phosphate buffered saline (PBS) was subsequently added to each well. After incubation at 37 oC for additional 4 h in a 5% CO2 humidified incubator, the remaining MTT solution was removed from wells and 150 μL dimethysulfoxide (DMSO) was added into each well to dissolve the intracellular blue-violet formazan crystals. The optimal density (OD) value was measured with a microplate reader (Model 680 Bio-RAD) at 570 nm wavelength. The cell viability was calculated as a percentage of the control culture value using the following formula: (ODtreated/ODcontrol)×100%.\nFor the co-staining of live and dead cells after various treatments including PTT, PDT and PDT+PTT, cells were further incubated for 12 hours before co-staining. The dye solution was prepared by adding 10 µL of Calcein AM (1.0 mmol L-1) and 15 µL of Propidium iodide (PI, 1.5 mmol L-1) solution to a 5 mL cell medium. Then 1.0 mL of dye solution was added to each plate and incubated for 30 minutes at 37 °C. Finally, the cells were washed with PBS for three times to remove the excess dye solution and imaged by the Leica SP5 Confocal microscopy system (Calcein AM λex = 488 nm, λem = 515 nm; PI λex = 535 nm, λem = 617 nm).\nIn vivo imaging\nTumor-bearing mice were i.v. injected with 200 µL of IR825@P(PEGMA-co-APMA)-b-PMMA@TCPP/Mn micelles ([IR825] = 0.5 mg mL-1, [TCPP] = 1.8 mg mL-1) via tail vein administration. In vivo fluorescence imaging was conducted using the Maestro in vivo fluorescence imaging system (Cri Inc.) using red light (660 nm) as the excited wavelength, and the emission between 700-900 nm was collected. The autofluorescence was removed by the spectrum unmixing software. MR imaging was conducted by using a 3.0-T clinical MRI scanner (GE healthcare, USA) equipped with a special small animal imaging coil. After acquiring T1weighted MR images, the signal intensity was measured within a manually drawn region of interest for each mouse. For PA imaging, mice were i.v. injected with IR825@P(PEGMA-co-APMA)-bPMMA@TCPP/Mn micelles, and at different time points their\ntumors were scanned using the VisualSonic Vevo 2100 LAZR system (LZ400 probe, 30 MHz, 256-element linear array transducer).\nIn vivo combination therapy and histological examination\nMice bearing 4T1 tumors were randomly divided into four groups (n = 5 per group). The control group of mice were i.v. injected with 200 µL of PBS buffer, while the rest three groups of mice were i.v. injected with 200 µL of IR825@P(PEGMA-co-APMA)-bPMMA@TCPP/Mn micelles ([IR825] = 0.5 mg mL-1, [TCPP] = 1.8 mg mL-1). 24 hours after injection, PTT, PDT, and the combination therapy were conducted. For the PTT group, the tumors were irradiated with the 808-nm laser at a power density of 0.8 W/cm2 for 5 min. The temperature changes of the tumor site were monitored through an IR thermal camera (Infrared Cameras Inc.) during laser irradiation. For the PDT group, the tumors were irradiated with the 660-nm light at a power density of 5 mW/cm2 for 60 min. For the PDT plus PTT group, the mice were firstly exposed to the 808-nm laser for 5 min, and then irradiated with the 660-nm light for 60 min. After various treatments, the tumor sizes and body weights were monitored every two days for 14 days. The tumor volume was calculated according to the following formula: width2 × length/2.\nIn Hematoxylin and Eosin (HE) staining process, tumor tissues from each group were harvested 1 day after different treatments, fixed in 10% neutral buffered formalin, processed into paraffin, sectioned at 8 µm thickness. The obtained tumor slices were then stained with hematoxylin and eosin (H&E), and examined by a digital microscope (Leica QWin)."
    }, {
      "heading" : "Other characterizations",
      "text" : "Fourier transform infrared (FT-IR) spectra were recorded on a NICOLET-6700 FT-IR spectrometer using solid samples dispersed in KBr pellets. Transmission electron micrographs (TEM) were taken with a FEI Tecnai G220 operated at an accelerating voltage of 120 kV. The sample was prepared by mounting a drop of the nanoparticle dispersion on a carbon-coated Cu grid and allowing the sample to dry in air. The sizes of nanoparticles were measured using ZEN3690 zetasizer (Malvern, USA). The concentration of manganese in IR825@P(PEGMA-co-APMA)-b-PMMA@TCPP/Mn samples were measured by inductively coupled plasma atomic emission spectroscopy (ICP-AES).\nIR825@P(PEGMA-co-APMA)-b-PMMA@TCPP/Mn micelle solutions with different manganese concentrations ranging from 0.075 mM to 1.2 mM were scanned under a 3.0 T clinical MR scanner (GE Healthcare, USA) at room temperature. After acquiring the T1-weighted MR images, the signal intensity of each sample was measured by drawing regions-of-interest (ROI). By plotting the r1 value (1/T1) for each sample against the Mn concentration, the final r1 value for IR825@P(PEGMA-co-APMA)-b-PMMA@TCPP/Mn was calculated by curve fitting.\nAbsorption spectra were determined on a Shimadzu UV-2600 spectrophotometer. Emission spectra were recorded on a FluoroMax4 fluorescence spectrometer (Horiba Jobin Yvon). 1H NMR and 13C NMR spectra were recorded on Bruker 300 MHz nuclear magnetic resonance (NMR) instrument at ambient temperature. Highresolution mass spectra were recorded on a Finnigan MAT95 mass spectrometer. Melting points were determined on an X-4 electrothermal apparatus with microscope (Taike, China). pH\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n2 8\nJu ly\n2 01\n6. D\now nl\noa de\nd by\nC or\nne ll\nU ni\nve rs\nity L\nib ra\nry o\nn 28\n/0 7/\n20 16\n1 1:\n26 :1\n9.\nView Article Online DOI: 10.1039/C6NR04835H\nARTICLE  Journal Name \n6 | J.  Name., 2014, 00, 1‐3  This journal is © The Royal Society of Chemistry 2014 \nmeasurements were made with a Lei-Ci (pH-3C) digital pH meter (Shanghai, China) using a combined glass-calomel electrode. The number-average molecular weight (Mn) and molecular weight distribution (Mw/Mn) values of the resultant polymers were determined using a TOSOH HLC-8320 gel permeation chromatograph (GPC) equipped with a refractive-index detector (TOSOH), using TSKgel guardcolumn SuperMP-N (4.6 × 20 mm) and two TSKgel SupermultiporeHZ-N (4.6 × 150 mm) with measurable molecular weight ranging from 5×102 to 5×105 g mol-1. THF was used as the eluent at a flow rate of 0.35 mL min-1 under 40 oC. GPC samples were injected using a TOSOH plus autosampler and calibrated with poly (methyl methacrylate) standards purchased from TOSOH."
    }, {
      "heading" : "Results and discussion",
      "text" : "Design and synthesis of P(PEGMA-co-APMA)-b-PMMA copolymer\nScheme 1. Synthetic routes of P(PEGMA-co-APMA)-bPMMA via consecutive RAFT polymerizations and subsequent modification.\nThe block copolymer poly[(poly(ethylene glycol) methyl ether methacrylate)-co-3-aminopropyl methacrylate]-blockpoly(methyl methacrylate) (P(PEGMA-co-APMA)-b-PMMA) was chosen as a skeleton to construct a polymeric nanoplatform for tumor-targeted combined photothermal and photodynamic therapy. The detailed route to synthesize the diblock copolymer by a three-step procedure was illustrated in Scheme 1. Poly(ethylene glycol) methyl ether methacrylate (PPEGMA) was selected as the hydrophilic segment due to its good water solubility, satisfying biocompatibility, long circulating life time, and preferential accumulation in the tumor tissues with the enhanced permeability and retention (EPR) effect. Prior to the random copolymerization of PEGMA and an amino functional monomer, the protection of amine groups is\nessential since amines would attack the dithioester functional group and reduce the functionality of the RAFT agent via a nucleophilic substitution reaction.68-70 The synthesis of P(PEGMA-co-BAPMA) was carried out by the RAFT polymerization using 2-cyanoprop-2-yl 1-dithionaphthalate (CPDN) as the chain transfer agent, in which reactive tert-butyl carbamate (BOC) units were introduced into the polymer structure as the potential crosslinking sites, given that the protective groups could offer an optimized access to obtain amino functional groups. The synthesized macro-RAFT agent P(PEGMA-co-BAPMA) was used for chain extension with methyl methacrylate (MMA) to yield the block copolymer P(PEGMA-co-BAPMA)-b-PMMA in the next immediate step, and subsequent removal of the BOC protective groups using trifluoroacetic acid (TFA) provided targeted polymer P(PEGMA-co-APMA)-b-PMMA.\nThe schematic illustration of the nano-micelle formation and proposed multimodal imaging-guided tumor-targeted photothermal and photodynamic combination therapy behaviors was presented in Scheme 2. The PMMA block serving as the hydrophobic core of the micelles was introduced in order to obtain loading sites of the photothermal agent (IR825). IR825 loaded uncross-linked micelles were facilely prepared by integrating IR825 molecules inside hydrophobic cores through a simple self-assembly process: by dropwise addition of a solution of P(PEGMA-co-APMA)-b-PMMA and IR825 in DMSO to distilled (DI) water followed by the dialysis treatment, well-distributed micelles with spherical morphologies were then obtained. The shell cross-linked micelles were further fabricated by using 5,10,15,20-tetrakis (4- carboxyphenyl) porphyrin (TCPP) as a tetra-functional crosslinker. The amine bearing segment prepared by further deprotection of PBAPMA was used to act as a functional reaction site for the conjugation of the TCPP crosslinkers. The structural stability and integrity of the polymeric micelles in a typical biological environment were subsequently enhanced, and the release of IR825 was greatly inhibited. IR825 contributed the photothermal therapy (PTT) and the photoacoustic (PA) imaging abilities to the prepared micelles. Besides, the red-emitting TCPP also provided manganese-II (Mn2+) binding sites to form chelation complex, making the formed micelles obtain the advantages of photodynamic therapy (PDT) with fluorescence and magnetic resonance (MR) imaging abilities. PA, MR and fluorescence imaging could be conducted to identify the exact locations of tumors, while the combined PTT and PDT will be induced to precisely ablate the tumors with minimal damage to the nearby tissues. In this strategy, PA, MR and fluorescence imaging-guided photothermal and photodynamic cancer treatment using our prepared micelles was a promising therapeutic strategy to inhibit tumor growth and provide a significant advantage in prolonging the survival of animals.\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n2 8\nJu ly\n2 01\n6. D\now nl\noa de\nd by\nC or\nne ll\nU ni\nve rs\nity L\nib ra\nry o\nn 28\n/0 7/\n20 16\n1 1:\n26 :1\n9.\nView Article Online DOI: 10.1039/C6NR04835H\nJournal Name RSCPublishing\nARTICLE \nThis journal is © The Royal Society of Chemistry 2014  J. Name., 2014, 00, 1‐3 | 7 \nScheme 2. Schematic illustration of the formation of shell crosslinking micelles and the PA, MR and fluorescence tripe-model imaging-guided combined photothermal and photodynamic therapy functionalities.\n1H NMR was utilized to characterize the structures of the asprepared copolymers. As shown in Fig. 1, all the characteristic peaks of PEGMA (4.01 ppm (s, CO2CH2CH2), 3.40-3.59 ppm (m, CH2CH2O), 3.23 ppm (s, OCH3)), and BAPMA (6.73 ppm (s, CH2NHCO2), 2.99 ppm (s, CH2CH2NH), 1.38 ppm (s, CO2C(CH3)3)) units appeared in the 1H NMR spectrum of purified P(PEGMA-co-BAPMA) using DMSO-d6 as the solvent, and the amide groups located at 6.73 ppm. When CDCl3 was employed as the solvent, the most obvious difference is that the active hydrogen chemical shift of amino was appeared at 5.42 ppm (Fig. S6†). Although the characteristic peaks of PMMA units (0.74-2.01 ppm (m, CH2CCH3), 3.56 ppm (c, COOCH3)) were overlapped with other units of P(PEGMA-co-BAPMA) in the 1H NMR spectrum, the integral values of corresponding area has an obvious increase (Fig. S6-S7†). GPC (Fig. S8†) and 1H NMR analysis demonstrated that there is a clear molecular weight increase for P(PEGMA-co-BAPMA)-b-PMMA in comparison to the P(PEGMA-co-BAPMA) precursor. The above results confirmed the successful synthesis of the target diblock copolymer P(PEGMA-co-BAPMA)-b-PMMA by consecutive RAFT techniques with good controllability of living radical polymerizations.\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n2 8\nJu ly\n2 01\n6. D\now nl\noa de\nd by\nC or\nne ll\nU ni\nve rs\nity L\nib ra\nry o\nn 28\n/0 7/\n20 16\n1 1:\n26 :1\n9.\nView Article Online DOI: 10.1039/C6NR04835H\nARTICLE  Journal Name \n8 | J.  Name., 2014, 00, 1‐3  This journal is © The Royal Society of Chemistry 2014 \nFig. 1 1H NMR spectra of P(PEGMA-co-BAPMA)-b-PMMA (a) and P(PEGMA-co-APMA)-b-PMMA (b) in DMSO-d6 for the illustration of BOC protective group deprotection from the PBAPMA segment.\nAs a result of the use of PMMA as the GPC standard sample, the absolute molecular weights determined by GPC analysis had certain deviations from the actual values. The actual composition of the copolymer provided by the calculation of the integrity ratios in the 1H NMR spectra would provide more accurate information. The results shown in Fig. S6† revealed the PPEGMA and PBAPMA segments with approximately 67.5 and 26.7 repeating units, respectively, which was determined by calculating the integral ratio of the peaks at around 7.5 ppm belonging to the RAFT agent CPDN (c, d), the peak at 3.38 ppm of the methoxyl units (–OCH3) of the pendant poly(ethylene glycol) (PEG) chains and the peak at 3.19 ppm of the ethyl repeated groups (g) of PBAPMA segment. Thus the corresponding copolymer could be labeled as P(PEGMA67.5-coBAPMA26.7). In a similar calculation method, P(PEGMA67.5-coBAPMA26.7)-b-PMMA66.2 was obtained (Fig. S7†). 1H NMR analysis also proved the almost complete removal of the BOC protection groups on the polymer chains to provide target products (Fig. 1, Fig. S9†).\nWith intensive absorption in the near-infrared (NIR) region, the non-fluorescent IR825 has been investigated extensively as a highly effective photothermal tumor ablation agent by reason of its excellent optical properties and high photothermal conversion\nefficiency.54, 58, 71, 72 It can be easily dissolved in many organic solvents, such as EtOH, DMF and DMSO, but its solubility in aqueous phase was rather poor. Besides, the biological application of free IR825 molecular was also limited by several other major disadvantage factors belonging to heptamethine indocyanine dyes, such as self-aggregation, nonspecific protein binding, and rapid renal elimination from tissues. In order to improve the solubility and the therapeutic efficiency of this model functional agent in physiological medium, IR825 was encapsulated into the hydrophobic cores of the micelles by a simple self-assembly process. A classical dialysis technique was adopted to investigate the difference of IR825 loading behaviors of P(PEGMA-co-APMA)-b-PMMA with various feed ratios in the uncross-linked micelles. A series of IR825 loaded micelles formulated with different content of IR825 was prepared. Encapsulation efficiency, entrapment efficiency and particle sizes of IR825 loaded micelles with different reagent amounts used were evaluated as shown in Table 1. The results showed that when a constant amount of polymer was used, entrapment efficiency (DLC) raised as IR825 feeding ratio increased, yet simultaneously leading to a decrease in encapsulation efficiency (DLE) to a certain degree. IR825 encapsulated micelles prepared under the desired feed ratio of 100/5 (w/w) with high encapsulation efficiency (82.4%), welldistributed morphology and narrow distributions (PDI) were selected in our following studies. Besides, blank micelles without IR825 encapsulation had an average hydrodynamic diameter of 71 nm (PDIDLS = 0.112).\nTable 1. Encapsulation efficiency, entrapment efficiency and particle size of IR825 loaded micelles with different amounts used.\nEntry Polymer (mg) IR825 (mg) DLC (wt%)a\nDLE(%)b Size (nm)c PDIc Theory Determined\n1 50 2.0 3.8 3.3 85.5 72 0.109\n2 50 5.0 9.1 6.9 74.6 87 0.122\n3 100 5.0 4.8 4.0 82.4 82 0.124\n4 100 10.0 9.1 7.1 76.8 96 0.132\n5 100 15.0 13.0 9.3 68.4 126 0.158\naDrug loading content (DLC, wt%) = (amount of drug in micelles)/(amount of drug and polymer in micelles) × 100; bdrug loading efficiency (DLE, wt%) = (amount of drug in micelles)/(total amount of feeding drug) × 100; csize and distributions were determined by DLS measurements.\nTo acquire multi-modal imaging and photodynamic therapy functionalities, TCPP, as a red-emitting photo sensitizing molecular,73-75 was conjugated to IR825@P(PEGMA-coAPMA)-b-PMMA micelles as a crosslinker with subsequent Mn2+ chelation, and then IR825@P(PEGMA-co-APMA)-bPMMA@TCPP/Mn micelles were obtained. The TCPP molecular was covalently conjugated to the shell of IR825@P(PEGMA-co-APMA)-b-PMMA micelles via the formation of amide bonds between carboxylic groups of TCPP and amino groups in PAPMA segment of the block copolymers. There are four functional junctions in the molecular structure of TCPP, the crosslinking would have greater efficiency and effectiveness than the traditionally used di-functional crosslinkers.76-78 The detailed experimental process was provided in the experimental section. The occurrence of shell crosslinking was also confirmed by the model reaction of amino functional diblock copolymer P(PEGMA-co-APMA)-bPMMA and TCPP. Briefly, the alkaline solution (Na2HPO4citric acid buffer solution, pH 8.5, 0.1 M) of TCPP (10 mg) was added into a IR825@P(PEGMA-co-APMA)-b-PMMA (100 mg) solution under vigorous stirring, and N-(3dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC, 15 mg) was added as a catalyst. After reaction for 24 h, TCPP was covalently conjugated to amino groups of the polymer by amide formation, the above solution was then purified by dialysis to remove unbounded TCPP, then the final product P(PEGMA-co-APMA)-b-PMMA@TCPP was obtained. Upon comparison of free TCPP and the conjugated polymer in 1H NMR spectra, the significant decrease of characteristic signal of amine functional groups in polymer chains at 7.80 ppm and the disappearance of carboxylic group signals from TCPP at 10.41 ppm were detected, which was feasibly\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n2 8\nJu ly\n2 01\n6. D\now nl\noa de\nd by\nC or\nne ll\nU ni\nve rs\nity L\nib ra\nry o\nn 28\n/0 7/\n20 16\n1 1:\n26 :1\n9.\nView Article Online DOI: 10.1039/C6NR04835H\nJournal Name  ARTICLE \nThis journal is © The Royal Society of Chemistry 2014  J. Name., 2014, 00, 1‐3 | 9 \nattributed to the formation of acylamino linkages after TCPP conjugation (Fig. S10†). The characteristic peaks of hydrogen atoms of benzene rings and pyrrole parts in the TCPPconjugated polymer exhibited slight broadening signals compared with free TCPP. The TCPP-based crosslinker not only has the general functions of the crosslinking in micelle structures, but also possess the function of fluorescence imaging and photodynamic therapy, and can be further used for magnetic imaging after Mn2+ chelation, thus this crosslinking structure in the micelle composition has a very crucial role.\nUV-Vis-NIR absorbance spectra demonstrated the characteristic peaks of IR825 (832 nm) in the IR825@P(PEGMA-co-APMA)-b-PMMA micelles after IR825 loading. As a derivative of porphyrin, TCPP can serve as a chelating reagent to capture Mn2+ as the commonly used T1 weighted MR contrast agent. After crosslinking and metal ions chelation, the obtained IR825@P(PEGMA-co-APMA)-bPMMA@TCPP/Mn micelles still retained characteristic absorption band of IR825, and a red shift phenomenon occurred compared with the absorption of free IR825 molecules and IR825@P(PEGMA-co-APMA)-b-PMMA micelles (846 nm, Fig. 2), which may be due to the enhanced structural stability and integrity. The new emerging absorption peaks, with Soret band at 419 nm and Q bands at 519, 555, 595 and 653 nm, were totally attributed to the characteristic absorption features of TCPP. The Soret band of IR825@P(PEGMA-co-APMA)-bPMMA@TCPP/Mn micelles was slightly red-shifted by 5 nm compared to that of free TCPP in MeOH or buffer solution (pH 8.5). The changes in the absorbance spectra after conjugation to IR825@P(PEGMA-co-APMA)-b-PMMA micelles indicated dissociation of the H-type aggregation character of TCPP.79, 80 The content of IR825 and TCPP in nanoparticles was determined to be 3.47% and 12.38% (w/w) by the UV quantitative analysis, respectively (Fig. S13†).\nWith TCPP anchored on, the IR825@P(PEGMA-coAPMA)-b-PMMA@TCPP micelles not only has the ability of fluorescence imaging, but also can provide the binding sites for the Mn2+ chelation at a molar ratio of 1:1 (nTCPP : nmanganese-II) as disclosed by inductively coupled plasma (ICP) analysis. The emission spectra of IR825@P(PEGMA-co-APMA)-bPMMA@TCPP micelles and IR825@P(PEGMA-co-APMA)b-PMMA@TCPP/Mn micelles were shown in Fig. S14†. Although a partial quenching of TCPP fluorescence with essentially unchanged emission peak at 650 nm was observed in micelles after Mn2+ chelation, it still provided an obvious red emission band ranging from 620 nm to 760 nm for bio-imaging. To explore the application prospect of IR825@P(PEGMA-coAPMA)-b-PMMA@TCPP/Mn used as a T1 weighted MR contrast agent, the T1 relaxation time as a function of Mn2+ concentration was measured as illustrated in Fig. 6h, and our prepared micelles showed a distinct concentration-dependent brightening effect in the T1-weighted MR images. The transverse relaxivity value (r1) was calculated to be 9.53 mM−1 S−1, which appeared to be much higher than that of the clinic approved T1 MR contrast agent, Magnevist (DTPA-Gd) (4.25 mM−1 S−1).81, 82 The fluorescence imaging and contrasting T1weighted MR imaging abilities provided essential theoretical evidence for the diagnosis of tumors.\nOwing to the high NIR absorbance contributed by IR825, the prepared nano-micelles exhibited rapid temperature increase under an 808-nm laser irradiation for 5 min at the power density of 0.8 W/cm2 (Fig. 2d), suggesting the excellent photothermal capacity of the polymeric nanoparticles. By contrast, pure water showed litter change. TCPP segments also play a critical role in our designed system to serve as the generator of singlet oxygen (1O2). The singlet oxygen production abilities of IR825@P(PEGMA-co-APMA)-bPMMA@TCPP/Mn micelles were assessed by a typical singlet oxygen sensor green reagent (SOSG, a molecular sensor, USA).83 Under the 660-nm light irradiation at the power density of 5 mW/cm2, the 1O2 generation based on the fluorescence recovery of SOSG with different laser irradiation time was shown in Fig. 2e. Obvious production of 1O2 was detected, although the 1O2 production efficiency of IR825@P(PEGMAco-APMA)-b-PMMA@TCPP/Mn micelles was slightly quenched compared with that of free TCPP at the same concentration. The partially decreased 1O2 production ability was mainly attributed to the chelation of manganese ions (Mn2+), and the micelles were still proved to be good lightinduced 1O2 generators. The 1O2 production assessment of Mn2+-chelated TCPP has not been measured since free TCPP precipitated immediately upon chelation with Mn2+ in the buffer solution (pH 8.5). Therefore, the photothermal capacity and 1O2 generation ability of IR825@P(PEGMA-co-APMA)-bPMMA@TCPP/Mn micelles allowed to be used as a potential agent for photothermal and photodynamic cancer treatments.\nThe transmission electron microscopy (TEM) images obtained for the uncross-linked micelles exhibited uniform morphology of well-distributed spherical shapes with diameter ranging from 70 to 90 nm (Fig. 3). Dynamic light scattering (DLS) measurement revealed that the average size of these well-dispersed micelles was 82 nm with a relative narrow distribution (PDIDLS = 0.124) (Fig. 2b). The DLS and TEM analysis results also showed that the average size has slightly decreased when these IR825 encapsulated micelles were crosslinked with TCPP agents (78 nm, PDIDLS = 0.102), which can be explained by the fact that the corresponding swelling and chain stretching were reduced during crosslinking process. Due to the existence of excess un-reacted carboxyl groups on the TCPP bridges, IR825@P(PEGMA-co-APMA)-bPMMA@TCPP/Mn micelles appeared to be negatively charged with a zeta potential of -5.6 mV. The prepared nanoparticles also exhibited satisfying stability in different physiological medium such as phosphate buffered saline (PBS) and fetal bovine serum (FBS).\nStability investigation experiments were studied by dispersing IR825@P(PEGMA-co-APMA)-b-PMMA micelles and IR825@P(PEGMA-co-APMA)-b-PMMA@TCPP/Mn micelles at 37 oC in PBS buffer solution (pH 7.4) for different periods of time in the dialysis processes. After the treatment of centrifugal separation, retention amounts of IR825 in micelle samples at different time points were then determined by the UV-Vis-NIR spectroscopy. As shown in Fig.3, time-dependent absorption properties of uncross-linked micelles indicated that IR825 molecular locating in the uncross-linked micelles was degraded partially with a new absorption peak appearing at 675\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n2 8\nJu ly\n2 01\n6. D\now nl\noa de\nd by\nC or\nne ll\nU ni\nve rs\nity L\nib ra\nry o\nn 28\n/0 7/\n20 16\n1 1:\n26 :1\n9.\nView Article Online DOI: 10.1039/C6NR04835H\nARTICLE  Journal Name \n10 | J.  Name., 2014, 00, 1‐3  This journal is © The Royal Society of Chemistry 2014 \nnm. The reservation amount of IR825 obviously decreased over time, and the content of IR825 was only 36.4% after 150 h of incubation. While in the case of TCPP-crosslinked micelles, the stability was significantly improved, and the majority of IR825 dye molecules (80.3%) retained being loaded in nanoparticles after 150 h incubation in PBS buffer solution.\nFig. 2 (a) UV-Vis-NIR spectra of IR825 (6.30 μM, in methanol), IR825 (6.30 μM, in DMF), TCPP (7.67 μM, in methanol), TCPP (7.67 μM, in pH 8.5 buffer solution), IR825@P(PEGMA-co-APMA)-b-PMMA micelles (polymer: 145.6 μg mL-1, IR825: 6.0 μg mL-1), and IR825@P(PEGMAco-APMA)-b-PMMA@TCPP/Mn micelles (polymer: 72.8 μg mL-1, IR825: 3.0 μg mL-1, TCPP: 10.7 μg mL-1). (b) Hydrodynamic diameters of IR825@P(PEGMA-co-APMA)-bPMMA micelles. (c) Hydrodynamic diameters of IR825@P(PEGMA-co-APMA)-b-PMMA@TCPP/Mn micelles. (d) Temperature change curves of different solutions over a period of 5 min under exposure to the 808-nm light (0.8 W/cm2). (e) The time-dependent recovered fluorescence of SOSG (excitation wavelength was 494 nm) for determination of singlet oxygen generation by free TCPP (1.0 μM) or IR825@P(PEGMA-co-APMA)-b-PMMA@TCPP/Mn micelles (polymer: 5.37 μg mL-1, IR825: 0.22 μg mL-1, TCPP: 0.79 μg mL-1) irradiated with a 660-nm light exposure at the power density of 5 mW/cm2.\nFig. 3 (a1-3) TEM images of IR825@P(PEGMA-co-APMA)-b-PMMA micelles; (a4-6) TEM images of IR825@P(PEGMA-coAPMA)-b-PMMA@TCPP/Mn micelles. (b) Retention amount of IR825 in micelle samples at 37 oC in PBS buffer solution for\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n2 8\nJu ly\n2 01\n6. D\now nl\noa de\nd by\nC or\nne ll\nU ni\nve rs\nity L\nib ra\nry o\nn 28\n/0 7/\n20 16\n1 1:\n26 :1\n9.\nView Article Online DOI: 10.1039/C6NR04835H\nJournal Name  ARTICLE \nThis journal is © The Royal Society of Chemistry 2014  J. Name., 2014, 00, 1‐3 | 11 \ndifferent periods of time. (c) Time-dependent absorption properties of IR825@P(PEGMA-co-APMA)-b-PMMA micelles (polymer: 266.9 μg mL-1, IR825: 11.0 μg mL-1) at 37 oC in PBS buffer solution. (d) Absorption spectra of IR825@P(PEGMA-coAPMA)-b-PMMA@TCPP/Mn micelles (polymer: 76.6 μg mL-1, IR825: 3.16 μg mL-1, TCPP: 11.3 μg mL-1) at 37 oC in PBS buffer solution before and after stability investigation.\nBased on the standard thiazolyl tetrazolium (MTT) assay, IR825@P(PEGMA-co-APMA)-b-PMMA@TCPP/Mn micelles exhibited great biocompatibility and negligible cytotoxicity under dark conditions even at high concentrations up to 100 μg mL-1 for 24 h of incubation with 4T1 murine breast cancer cells (Fig. 4a). The cellular uptake of IR825@P(PEGMA-coAPMA)-b-PMMA@TCPP/Mn micelles was then monitored after their incubation with 4T1 cells for different periods of time. By the confocal fluorescence microscopy the corresponding cellular fluorescence images contributed by TCPP were illustrated in Fig. 4e. Significant fluorescence signals were detected in the cytoplasm of 4T1 cells under 633- nm excitation by a time-dependent manner. These experiment results clearly demonstrated the effective cellular uptake of IR825@P(PEGMA-co-APMA)-b-PMMA@TCPP/Mn micelles, which may be promising for enhancing the in vitro photothermal and photodynamic efficacy of nanoparticles.\nTo study the photodynamic treatment effect of the micelles, 4T1 cells were incubated with free TCPP and IR825@P(PEGMA-co-APMA)-b-PMMA@TCPP/Mn micelles at different concentrations. The MTT assay indicated that the relative cell survival rate dropped as the increase of TCPP concentrations under 660-nm light exposure (optical dose 18 J cm-2, Fig. 4b) and the micelles treated with free TCPP displayed almost no obvious cytotoxicity without light irradiation (Fig. S16†), suggesting the photosensitizer was effective in photodynamic elimination of cancer cells. It should be pointed out that, the in vitro photodynamic cancer destruction efficiency of obtained micelles turned out to be slightly lower than that of free TCPP. This was consistent with the previous test results that 1O2 generation ability of the micelles was slightly inferior to free TCPP. In addition, the pthotothermal efficiency of the micelles on cancer cells was accessed under 808-nm laser irradiation as shown in Fig. 4c. As expected, the micelles showed efficient photothermal cell killing abilities, and the photothermal efficacy was also observed in a concentration-dependent manner. The differences of the two kinds of processing methods is that PTT is able to\nplay a direct role by heperthermia within a short period of irradiation, while PDT depending on the generation of reactive oxygen species to kill cancers with lower synergistic powers usually takes a much longer irradiation period.\nNext, the use of IR825@P(PEGMA-co-APMA)-bPMMA@TCPP/Mn micelles as a theranostic agent for the combined effect of photothermal and photodynamic cancer treatment was evaluated in vitro (Fig. 4d). 4T1 cells was initially incubated with various concentrations of IR825@P(PEGMA-co-APMA)-b-PMMA@TCPP/Mn micelles for 6 h, after which, PDT (660-nm, 5 mW/cm2, 60 min), PTT (808-nm, 0.8 W/cm2, 5 min), as well as the combined treatment (PDT+PTT) were conducted in different groups of cancer cells, and then the cells were incubated for further 24 h in fresh cell medium followed by the cell viability determination. It was found that either single PDT or PTT treatment could only induce partial cell death at the current therapy conditions. In marked contrast, cancer cells upon the PTT and PDT combination treatment were prominently killed with rather low cell viabilities. The enhanced therapeutic effects may probably attributed to the fact that mild rise of photothermal temperature (e.g., to ~43 oC) could facilitate the cellular uptake of functional agents and thus improve the overall therapeutic efficiencies in combined therapies, as reported by many literatures.84-86 From another point of view, the low PDT effect before PTT treatment could also came from protected structure of TCPP in the polymeric micelle skeleton, and the enhanced combination effect using PTT followed by PDT could also be attributed to the opened TCPP structure with good light absorption. As shown in Fig. 4f, fluorescence images of Calcein AM and Propidium iodide (PI) cell co-staining results also revealed the intuitional synergistic effects of combined PTT and PDT induced by the micelles, in which the cells (Propidium iodide, PI, red) were almost completely destructed in combination treatment groups, while the proportion of live cells (Calcein AM, green) prevailed over dead cells in the single treatment group of PTT or PDT.\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n2 8\nJu ly\n2 01\n6. D\now nl\noa de\nd by\nC or\nne ll\nU ni\nve rs\nity L\nib ra\nry o\nn 28\n/0 7/\n20 16\n1 1:\n26 :1\n9.\nView Article Online DOI: 10.1039/C6NR04835H\nJournal Name RSCPublishing\nARTICLE \nThis journal is © The Royal Society of Chemistry 2014  J. Name., 2014, 00, 1‐3 | 12 \nFig. 4 (a) Relative viabilities of 4T1 cells after being incubated with IR825@P(PEGMA-co-APMA)-b-PMMA@TCPP/Mn with different concentrations. Relative viabilities of 4T1 cells treated by IR825@P(PEGMA-co-APMA)-b-PMMA@TCPP/Mn with 660-nm light exposure at the power density of 5 mW/cm2 for 60 min (b) or 808-nm laser irradiation at 0.8 W/cm2 for 5 min (c). (d) Relative viabilities of 4T1 cells for different treatment groups after being incubated with IR825@P(PEGMA-co-APMA)-bPMMA@TCPP/Mn with different concentrations. (e) Confocal fluorescence images of IR825@P(PEGMA-co-APMA)-bPMMA@TCPP/Mn micelles (20 μg mL-1) transfected 4T1 cells at different time points. Green and blue color represented fluorescence of micelles and DAPI-stained cell nuclei, respectively. (f) Confocal fluorescence microscope images of Calcein AM and PI co-stained 4T1 cells after various treatments indicated. Green and red colors represented live and dead cells, respectively.\nFig. 5 In vivo PA images of 4T1 tumor bearing Balb/c mouse before (a) and after (b) i.v. injected with IR825@P(PEGMAco-APMA)-b-PMMA@TCPP/Mn micelles (200 µL, [IR825] = 0.5 mg mL-1, [TCPP] = 1.8 mg mL-1); (c) the corresponding PA signal values at the tumor areas.\nPhotoacoustic (PA) imaging tomography for the lightabsorbing tissue inspection relies on the light absorption and acoustic waves resulted from transient thermoelastic expansion.87 The dense packing of IR825 within the hydrophobic core of IR825@P(PEGMA-co-APMA)-bPMMA@TCPP/Mn micelles gave very high NIR absorption that would generate strong PA signals. As illustrated in Fig. 5, lighten PA images and obviously enhanced PA signals in tumor tissue after 24 h intravenous (i.v.) injection were detected due to the accumulation of nano-micelles by the EPR effect.\nTo further study the tumor-targeting ability of nanoparticles for in vivo fluorescence imaging, the circulation of IR825@P(PEGMA-co-APMA)-b-PMMA@TCPP/Mn micelles after i.v. injection into 4T1 murine breast tumor-bearing mice (200 μL, [IR825] = 0.5 mg mL-1, [TCPP] = 1.8 mg mL-1) was measured by tracking red-emitting fluorescence of TCPP sections. The micelle-administrated mice were spectrally imaged by a Maestro EX in vivo fluorescence imaging system (CRi, Inc.) as indicated in Fig. 6a. The micelles tended to be\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n2 8\nJu ly\n2 01\n6. D\now nl\noa de\nd by\nC or\nne ll\nU ni\nve rs\nity L\nib ra\nry o\nn 28\n/0 7/\n20 16\n1 1:\n26 :1\n9.\nView Article Online DOI: 10.1039/C6NR04835H\nJournal Name  ARTICLE \nThis journal is © The Royal Society of Chemistry 2014  J. Name., 2014, 00, 1‐3 | 13 \nprominently accumulated in the tumor area at early time points and enriched over time. The highest tumor uptake of nanoparticles was observed at 10 h post injection (p.i.) indicated by measuring red-emitting fluorescence intensities and tumor-to-normal tissue (T/N) ratios (Fig. 6d-e). By measuring TCPP fluorescence in the collected blood samples, a long blood circulation half-life, which was favorable for tumor passive targeting due to the well-known EPR effect, was determined to be ~3.64 h by secondary exponential fitting in blood circulation profile (Fig. 6i). To quantitatively analyze the bio-distribution of IR825@P(PEGMA-co-APMA)-bPMMA@TCPP/Mn micelles in major organs or tissues, these mice were then sacrificed at 24 h p.i. for ex vivo imaging of major organs by measuring the red emission signals of TCPP, the tumor was detected to have the brightest fluorescence among all organs, suggesting the high tumor uptake efficacy of these functional nanoparticles (Fig. 6b-c).\nAs one of the most extensively used clinical imaging modalities for whole body scanning, MR imaging can make up for the deficiencies of limited tissue penetration depth. In this work, porphyrin structures of TCPP crosslinkers served as the chelate ligand to capture Mn2+ for MR imaging. Fig. 6f described the cross-section T1-weighted MR imaging ability toward above 4T1 tumor-bearing mice before and after i.v. injection of IR825@P(PEGMA-co-APMA)-bPMMA@TCPP/Mn micelles. T1-weighted MR images showed the obviously brighten T1 MR signals in the tumor areas, indicating the high tumor uptake and superior contrasting ability of prepared micelles in T1-weighted MR imaging. Average T1 signals in the tumor areas were shown in Fig. 6g. Thus, TCPP, as both a red-emitting photosensitizer and a shellcrosslinker of fabricated micelles, enabled the additional fluorescence and magnetic resonance (MR) dual-modal imaging abilities for IR825@P(PEGMA-co-APMA)-bPMMA@TCPP/Mn micelles. So far, the IR825@P(PEGMAco-APMA)-b-PMMA@TCPP/Mn micelles were proved to be intrinsically triple-modal contrast agents for PA, MR and fluorescent imaging, and meanwhile the triple-modal imaging abilities revealed the fairly efficient tumor uptake of IR825@P(PEGMA-co-APMA)-b-PMMA@TCPP/Mn micelles, which encouraged us to apply the theranostic nanoparticles for potential clinical applications.\nFig. 6 (a) In vivo fluorescence imaging of 4T1 tumor-bearing mouse taken at different time points intravenous (i.v.) injection of IR825@P(PEGMA-co-APMA)-b-PMMA@TCPP/Mn micelles (200 µL, [IR825] = 0.5 mg mL-1, [TCPP] = 1.8 mg mL-1), dashed circles highlight the tumor. (b) Ex vivo fluorescence images of major organs and tumor dissected from mice at 24 h post-injection\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n2 8\nJu ly\n2 01\n6. D\now nl\noa de\nd by\nC or\nne ll\nU ni\nve rs\nity L\nib ra\nry o\nn 28\n/0 7/\n20 16\n1 1:\n26 :1\n9.\nView Article Online DOI: 10.1039/C6NR04835H\nARTICLE  Journal Name \n14 | J.  Name., 2014, 00, 1‐3  This journal is © The Royal Society of Chemistry 2014 \n(p.i.). Tu, Li, Sp, Ki, H, In and Lu stand for tumor, liver, spleen, kidney, heart, intestine and lung, respectively. (c) Semiquantitative relative biodistribution of IR825@P(PEGMA-co-APMA)-b-PMMA@TCPP/Mn in various organs as determined by the fluorescence intensities. (d) Plot of average fluorescence intensity values for tumor regions compared with normal tissue control region selected in vivo imaging data. (e) Plot of in vivo tumor contrast at each time point showing that high contrast was achieved by 10 h and was maintained for at least 24 h post-injection. (f) In vivo MR images of 4T1 tumor bearing Balb/c mouse administrated with IR825@P(PEGMA-co-APMA)-b-PMMA@TCPP/Mn micelles before and after administration of micelles (200 µL, [IR825] = 0.5 mg mL-1, [TCPP] = 1.8 mg mL-1); the red circle marks the tumor areas. (g) The corresponding T1 signal values at the tumor areas. (h) T1-weighted MR images (3.0 T; TR, 2000.00 ms; TE, 12.9 ms) and T1 relaxation rates (r1) of IR825@P(PEGMA-co-APMA)-b-PMMA@TCPP/Mn micelles at different Mn2+ concentrations. (i) Blood circulation curves of IR825@P(PEGMA-co-APMA)-b-PMMA@TCPP/Mn micelles in mice after i.v. injection determined based on measuring TCPP fluorescence in blood lysates.\nThe benefits of in vivo cancer treatment were subsequently studied. In the process of the photothermal effect investigation, an infrared (IR) thermal apparatus was employed to record the real-time temperature changes of the tumor area which was exposed to an 808-nm laser irradiation at a power density of 0.8 W/cm2 for 10 min. IR thermal images indicated a rapid temperature increase from ~36 oC to ~48 oC on the tumors of i.v. injected mice, whereas no significant heating effect for the saline buffer injected group was observed under the same irradiation condition as control (Fig. 7a). The temperature of tumor on mice with the injection of micelles maintained at ~48 oC (Fig. 7b), and the heating effect would be high enough for effective photothermal ablation of cancer cells, demonstrating the potential ability of implying IR825@P(PEGMA-coAPMA)-b-PMMA@TCPP/Mn micelles as the photothermal agent for in vivo cancer thearpy.\nIn view of the high tumor accumulation, multi-model imaging abilities, as well as effective therapeutic in vitro effects of  IR825@P(PEGMA-co-APMA)-b-PMMA@TCPP/Mn micelles, the therapeutic efficacies based on the ranostic nanomicelles were evaluated by in vivo experiments. 4T1 tumorbearing mice with initial tumor volumes of 100-150 mm3 were randomly divided into four groups (n = 5 per group). The first group injected with saline was used as a control. The other three groups of mice were i.v. injected with IR825@P(PEGMA-co-APMA)-b-PMMA@TCPP/Mn micelles (200 µL, [IR825] = 0.5 mg mL-1, [TCPP] = 1.8 mg mL-1), and then went through corresponding treatments (PDT, PTT, PDT+PTT) as indicated in Fig. 7d. The PDT treatment group was exposed to the 660-nm light at the power density of 5 mW/cm2 for 60 min to induce the 1O2 production for tumor ablation, and the PTT treatment was conducted under 808-nm laser irradiation at the power density of 0.8 W/cm2 to raise the tumor temperature to 48 °C and maintain for 5 min. Of\nparticular note is that the group of “PTT+PDT” indicated the treatments of PTT and PDT therapies in sequence. The reason for taking such a treatment order is that the photothermal ablation would offer therapeutic thermal benefit to photodynamic tumor removal in the combination treatment.\nUpon corresponding treatments, body weights (Fig. 7c) and tumor volumes (Fig. 7d) were supervised every couple of days. With only PTT or PDT treatment, tumor growth was inhibited partially in the first 6 days compared to the control group, yet rapid tumor growth continued to proceed later on. In marked contrast, combined PTT and PDT treatment could greatly inhibit the tumor development with high therapeutic efficacies, resulting in no obvious growth within 14 days (Fig. 7d-f). Besides, no evident body weight loss and less sign of unhealthy condition indicated scarcely any acute toxicity of our theranostic agent.\nIn order to look insight into the therapeutic effectiveness after the treatments mentioned above, the hematoxylin and eosin (H&E) staining assays were conducted to investigate the morphology and apoptosis of tumor cells. The tumor slices of each group were collected one day after corresponding treatments. As shown in Fig. 7g, single treatment of PDT or PTT could only cause less efficient damage to eliminate tumors, while the tumor slices under the photothermal and photodynamic combination therapy clearly revealed an obvious synergistic effect of tumor cell necrosis and apoptosis, further demonstrating the superior tumor inhibition efficacy of combined PTT and PDT therapy. In addition, neither noticeable damage nor inflammation was observed in harvested organs including the liver, spleen, kidney, heart and lung in histopathological examination (Fig. S17†). Thus the strategy for construction of IR825-encapsulated and TCPP-crosslinked theranostic polymeric micelles was successfully developed for excellent synergetic cancer ablation effects.\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n2 8\nJu ly\n2 01\n6. D\now nl\noa de\nd by\nC or\nne ll\nU ni\nve rs\nity L\nib ra\nry o\nn 28\n/0 7/\n20 16\n1 1:\n26 :1\n9.\nView Article Onlin DOI: 10.1039/C6NR04835H\nJournal Name RSCPublishing\nARTICLE \nThis journal is © The Royal Society of Chemistry 2014  J. Name., 2014, 00, 1‐3 | 15 \nFig. 7 In vivo combination therapy. (a) IR thermal images of 4T1 tumor-bearing mice under 808-nm laser irradiation (0.8 W/cm2) after i.v. injection of IR825@P(PEGMA-co-APMA)-b-PMMA@TCPP/Mn micelles (200 µL, [IR825] = 0.5 mg mL-1, [TCPP] = 1.8 mg mL-1) (upper row) and saline (lower row). (b) Tumor temperature changes of mice monitored by the IR thermal camera during laser irradiation as indicated in (a). (c) Body weight data of mice after various treatments indicated. (d) Tumor growth curves of different groups of mice after various treatments indicated (5 mice per group). Error bars were based on standard error of mean (SEM). (N.S. no significance, * p < 0.05, ** p < 0.01, *** p < 0.001). Photographs (e) and relative weight (f) of tumors collected from mice at the end of treatments with tumor lengths and widths measured by a digital caliper (day 14). (g) H&E stained images of tumors sliced from of different groups of mice after various treatments indicated."
    }, {
      "heading" : "Conclusions",
      "text" : "In this work, diblock copolymer P(PEGMA-co-APMA)-bPMMA based biocompatible organic micelles comprised three specific criteria: a water-soluble PPEGMA unit for the shell construction offered the micelles great stability in physiological environments and prolonged blood circulation half-life with efficient in vivo passive tumor-targeting ability; a reactive primary amine-bearing segment derived from the removal of BOC protective groups on the polymer backbone were randomly dispersed in micelle shells, allowing for the efficient attachment of the desirable TCPP as the cross-linkage; PMMA block, as a hydrophobic part, formed the core of the micelles for the effective encapsulation of an NIR-absorbing dye (IR 825). By transmission electron microscopy (TEM) and dynamic light scattering spectrometer (DLS) analysis, both uncrosslinked and crosslinked micelles exhibited well-defined spherical morphology with relatively little dimensions (~80 nm) and narrow distributions in aqueous phase. IR825 retention experimental results proved that the crosslinking process is a practical and effective way to increase the stability of the polymeric micelles. After being anchored on the polymer backbone and further chelated with manganese ion (Mn2+), TCPP, as an efficient photosensitizer, contributed red-emitting fluorescence, magnetism resonance, as well as photodynamic cell killing effect for the obtained nanoparticles. IR 825, which was simultaneously loaded in the prepared micelles, facilitated the PA imaging and photothermal heating therapy functions, PA, MR and fluorescence triple-modal imaging indicated the efficient tumor uptake of nanoparticles by the EPR effect and\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n2 8\nJu ly\n2 01\n6. D\now nl\noa de\nd by\nC or\nne ll\nU ni\nve rs\nity L\nib ra\nry o\nn 28\n/0 7/\n20 16\n1 1:\n26 :1\n9.\nView Article Online DOI: 10.1039/C6NR04835H\nARTICLE  Journal Name \n16 | J.  Name., 2014, 00, 1‐3  This journal is © The Royal Society of Chemistry 2014 \nprovided evidence for pathological diagnosis and clinical treatment. The triple-modal imaging guided integration of photothermal and photodynamic therapy was finally conducted in a 4T1 tumor in vivo model, showing remarkable enhanced synergistic anti-tumor effects upon systemic administration of these multifunctional nano-agents. Neither obvious body weight loss nor noticeable abnormality of mice was detected, indicating no apparent acute side effect in our conducted PTT and PDT combination therapy. Therefore, our study suggests that the developed IR825@P(PEGMA-co-APMA)-bPMMA@TCPP/Mn micelles with well-designed structure engineering could serve as a safe and multifunctional nanoplatform for multiple model imaging-guided cancer combined theranostics."
    }, {
      "heading" : "Acknowledgements",
      "text" : "The financial support from the National Natural Science Foundation of China (No. 21274100, 21234005), the Specialized Research Fund for the Doctoral Program of Higher Education (No. 20123201130001), the Project of Science and Technology Development Planning of Suzhou (No. ZXG201413, SYG201430), the Project of Science and Technology Development Planning of Jiangsu Province (No. BK20141192) and the Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) are gratefully acknowledged."
    }, {
      "heading" : "Notes and references",
      "text" : "1. H.-C. Yen, H. Cabral, P. Mi, K. Toh, Y. Matsumoto, X. Liu, H. Koori, A. Kim, K. Miyazaki, Y. Miura, N. Nishiyama and K. Kataoka, ACS Nano, 2014, 8, 11591-11602.\n2. Y. Shi, R. van der Meel, B. Theek, E. Oude Blenke, E. H. E. Pieters, M. H. A. M. Fens, J. Ehling, R. M. Schiffelers, G. Storm, C. F. van Nostrum, T. Lammers and W. E. Hennink, ACS Nano, 2015, 9, 3740- 3752.\n3. V. T. Huynh, S. Binauld, P. L. de Souza and M. H. Stenzel, Chem. Mater., 2012, 24, 3197-3211.\n4. N. Kamaly, B. Yameen, J. Wu and O. C. Farokhzad, Chem. Rev., 2016, 116, 2602-2663.\n5. M. Elsabahy, G. S. Heo, S.-M. Lim, G. Sun and K. L. Wooley, Chem. Rev., 2015, 115, 10967-11011.\n6. Y. Huang, R. Dong, X. Zhu and D. Yan, Soft Matter, 2014, 10, 6121- 6138.\n7. X. Liu, B. Chen, X. Li, L. Zhang, Y. Xu, Z. Liu, Z. Cheng and X. Zhu, Nanoscale, 2015, 7, 16399-16416.\n8. Y. Zhao, F. Sakai, L. Su, Y. Liu, K. Wei, G. Chen and M. Jiang, Adv. Mater., 2013, 25, 5215-5256.\n9. P. Yan, R. Wang, N. Zhao, H. Zhao, D.-F. Chen and F.-J. Xu, Nanoscale, 2015, 7, 5281-5291.\n10. N. R. Patel, B. S. Pattni, A. H. Abouzeid and V. P. Torchilin, Adv. Drug Deliver. Rev., 2013, 65, 1748-1762.\n11. V. P. Torchilin, Nat. Rev. Drug Discov., 2014, 13, 813-827. 12. Z. Ge and S. Liu, Chem. Soc. Rev., 2013, 42, 7289-7325. 13. X. Liu, Q. Chen, G. Yang, L. Zhang, Z. Liu, Z. Cheng and X. Zhu, J.\nMater. Chem. B, 2015, 3, 2786-2800.\n14. L. Wang, P.-P. Yang, X.-X. Zhao and H. Wang, Nanoscale, 2016, 8, 2488-2509.\n15.D. Lê, L. Liénafa, T. N. T. Phan, D. Deleruyelle, R. Bouchet, S. Maria, D. Bertin and D. Gigmes, Macromolecules, 2014, 47, 2420-2429.\n16. Y. Shi, C. F. van Nostrum and W. E. Hennink, ACS Biomater. Sci. Eng., 2015, 1, 393-404.\n17. L.-C. Lee, J. Lu, M. Weck and C. W. Jones, ACS Catal., 2016, 6, 784- 787.\n18. Y. Shao, C. Shi, G. Xu, D. Guo and J. Luo, ACS Appl. Mater. Inter., 2014, 6, 10381-10392.\n19. M. Callari, D. S. Thomas and M. H. Stenzel, J. Mater. Chem. B, 2016, 4, 2114-2123.\n20. Y. Yang, Y. Li, Q. Lin, C. Bao and L. Zhu, ACS Macro Lett., 2016, 5, 301-305.\n21. A. I. Jensen, T. Binderup, P. Kumar Ek, A. Kjær, P. H. Rasmussen and T. L. Andresen, Biomacromolecules, 2014, 15, 1625-1633.\n22. J. Eliezar, W. Scarano, N. R. B. Boase, K. J. Thurecht and M. H. Stenzel, Biomacromolecules, 2015, 16, 515-523.\n23. M. H. Stenzel, Chem. Commun., 2008, 3486-3503. 24. K. Matyjaszewski, Macromolecules, 2012, 45, 4015-4039. 25. S. Yamago and Y. Nakamura, Polymer, 2013, 54, 981-994. 26. M. Chen, M. Zhong and J. A. Johnson, Chem. Rev., DOI:\n10.1021/acs.chemrev.5b00671. 27. X. Liu, L. Zhang, Z. Cheng and X. Zhu, Chem. Commun., DOI:\n10.1039/C6CC05454D. 28. C. Boyer, V. Bulmus, T. P. Davis, V. Ladmiral, J. Liu and S. Perrier,\nChem. Rev., 2009, 109, 5402-5436. 29.M. R. Hill, R. N. Carmean and B. S. Sumerlin, Macromolecules, 2015,\n48, 5459-5469. 30. L. Cheng, C. Wang, L. Feng, K. Yang and Z. Liu, Chem. Rev., 2014,\n114, 10869-10939. 31. Q. Chen, H. Ke, Z. Dai and Z. Liu, Biomaterials, 2015, 73, 214-230. 32.Q. Tian, M. Tang, Y. Sun, R. Zou, Z. Chen, M. Zhu, S. Yang, J. Wang,\nJ. Wang and J. Hu, Adv. Mater., 2011, 23, 3542-3547. 33. C. Wang, L. Xu, C. Liang, J. Xiang, R. Peng and Z. Liu, Adv. Mater.,\n2014, 26, 8154-8162. 34. J. Liu, C. Wang, X. Wang, X. Wang, L. Cheng, Y. Li and Z. Liu, Adv.\nFunct. Mater., 2015, 25, 384-392. 35. D. Chen, C. Wang, X. Nie, S. Li, R. Li, M. Guan, Z. Liu, C. Chen, C.\nWang, C. Shu and L. Wan, Adv. Funct. Mater., 2014, 24, 6621-6628. 36. L. Cheng, K. Yang, Q. Chen and Z. Liu, ACS Nano, 2012, 6, 5605-\n5613. 37. Q. Chen, C. Liang, C. Wang and Z. Liu, Adv. Mater., 2015, 27, 903-\n910. 38. K. Yang, H. Xu, L. Cheng, C. Sun, J. Wang and Z. Liu, Adv. Mater.,\n2012, 24, 5586-5592. 39. S. Lal, S. E. Clare and N. J. Halas, Accounts Chem. Res., 2008, 41,\n1842-1851. 40. J. T. Robinson, S. M. Tabakman, Y. Liang, H. Wang, H. Sanchez\nCasalongue, D. Vinh and H. Dai, J. Am. Chem. Soc., 2011, 133, 6825- 6831.\n41. X. J. Song, Q. Chen and Z. Liu, Nano Res., 2015, 8, 340-354. 42. C. Zhu, L. Liu, Q. Yang, F. Lv and S. Wang, Chem. Rev., 2012, 112,\n4687-4735. 43. S. Y. Park, H. J. Baik, Y. T. Oh, K. T. Oh, Y. S. Youn and E. S. Lee,\nAngew. Chem. Int. Edit., 2011, 50, 1644-1647.\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n2 8\nJu ly\n2 01\n6. D\now nl\noa de\nd by\nC or\nne ll\nU ni\nve rs\nity L\nib ra\nry o\nn 28\n/0 7/\n20 16\n1 1:\n26 :1\n9.\nView Article Online DOI: 10.1039/C6NR04835H\nJournal Name  ARTICLE \nThis journal is © The Royal Society of Chemistry 2014  J. Name., 2014, 00, 1‐3 | 17 \n44. J. Tian, L. Ding, H.-J. Xu, Z. Shen, H. Ju, L. Jia, L. Bao and J.-S. Yu, J. Am. Chem. Soc., 2013, 135, 18850-18858.\n45. K. Han, S.-B. Wang, Q. Lei, J.-Y. Zhu and X.-Z. Zhang, ACS Nano, 2015, 9, 10268-10277.\n46. S. S. Lucky, K. C. Soo and Y. Zhang, Chem. Rev., 2015, 115, 1990- 2042.\n47. G. Obaid, M. Broekgaarden, A.-L. Bulin, H.-C. Huang, J. Kuriakose, J. Liu and T. Hasan, Nanoscale, 2016, 8, 12471-12503.\n48. M. Zheng, C. Yue, Y. Ma, P. Gong, P. Zhao, C. Zheng, Z. Sheng, P. Zhang, Z. Wang and L. Cai, ACS Nano, 2013, 7, 2056-2067.\n49. O. Taratula, C. Schumann, M. A. Naleway, A. J. Pang, K. J. Chon and O. Taratula, Mol. Pharm., 2013, 10, 3946-3958.\n50. X. Deng, Y. Liang, X. Peng, T. Su, S. Luo, J. Cao, Z. Gu and B. He, Chem. Commun., 2015, 51, 4271-4274.\n51. X. Sun, C. Wang, M. Gao, A. Hu and Z. Liu, Adv. Funct. Mater., 2015, 25, 2386-2394.\n52. Y. Yuan, Z. Wang, P. Cai, J. Liu, L.-D. Liao, M. Hong, X. Chen, N. Thakor and B. Liu, Nanoscale, 2015, 7, 3067-3076.\n53. B. Jang, J.-Y. Park, C.-H. Tung, I.-H. Kim and Y. Choi, ACS Nano, 2011, 5, 1086-1094.\n54. Q. Chen, C. Wang, L. Cheng, W. He, Z. Cheng and Z. Liu, Biomaterials, 2014, 35, 2915-2923.\n55. X. Song, C. Liang, H. Gong, Q. Chen, C. Wang and Z. Liu, Small, 2015, 11, 3932-3941.\n56.R. Lv, C. Zhong, R. Li, P. Yang, F. He, S. Gai, Z. Hou, G. Yang and J. Lin, Chem. Mater., 2015, 27, 1751-1763.\n57. Z. Fan, X. Dai, Y. Lu, E. Yu, N. Brahmbatt, N. Carter, C. Tchouwou, A. K. Singh, Y. Jones, H. Yu and P. C. Ray, Mol. Pharm., 2014, 11, 1109-1116.\n58. L. Cheng, W. He, H. Gong, C. Wang, Q. Chen, Z. Cheng and Z. Liu, Adv. Funct. Mater., 2013, 23, 5893-5902.\n59. M. Li, C. Teh, C. Y. Ang, S. Y. Tan, Z. Luo, Q. Qu, Y. Zhang, V. Korzh and Y. Zhao, Adv. Funct. Mater., 2015, 25, 5602-5610.\n60. Y. Yang, J. Liu, C. Liang, L. Feng, T. Fu, Z. Dong, Y. Chao, Y. Li, G. Lu, M. Chen and Z. Liu, ACS Nano, 2016, 10, 2774-2781.\n61. A. Samanta, K. K. Maiti, K.-S. Soh, X. Liao, M. Vendrell, U. S. Dinish, S.-W. Yun, R. Bhuvaneswari, H. Kim, S. Rautela, J. Chung, M. Olivo and Y.-T. Chang, Angew. Chem. Int. Edit., 2011, 50, 6089- 6092.\n62. N. I. Carruthers, J. M. Spitler, S.-C. Wong, D. J. Blythin, X. Chen, H.J. Shue, H. S. She, J. F. Lee, C. Rizzo, P. C. Ting and R. E. West Jr, Bioorg. Med. Chem. Lett., 1998, 8, 3059-3064.\n63.A. Duréault, Y. Gnanou, D. Taton, M. Destarac and F. Leising, Angew. Chem. Int. Edit., 2003, 42, 2869-2872.\n64. L. Bai, L. Zhang, J. Pan, J. Zhu, Z. Cheng and X. Zhu, Macromolecules, 2013, 46, 2060-2066.\n65. D. Daly, A. Al-Sabi, G. K. Kinsella, K. Nolan and J. O. Dolly, Chem. Commun., 2015, 51, 1066-1069.\n66.X. Peng, F. Song, E. Lu, Y. Wang, W. Zhou, J. Fan and Y. Gao, J. Am. Chem. Soc., 2005, 127, 4170-4171.\n67. W. He, L. Cheng, L. Zhang, Z. Liu, Z. Cheng and X. Zhu, Polym. Chem., 2014, 5, 638-645.\n68. J. Xu, J. He, D. Fan, X. Wang and Y. Yang, Macromolecules, 2006, 39, 8616-8624.\n69. C. Boyer, A. Granville, T. P. Davis and V. Bulmus, J. Polym. Sci. Pol. Chem., 2009, 47, 3773-3794.\n70. X. Jiang, Y. Luo, Z. Li, L. Zhang, Z. Cheng and X. Zhu, Polym. Chem., 2015, 6, 6394-6401.\n71. Q. Chen, C. Liang, X. Wang, J. He, Y. Li and Z. Liu, Biomaterials, 2014, 35, 9355-9362.\n72. H. Gong, Z. Dong, Y. Liu, S. Yin, L. Cheng, W. Xi, J. Xiang, K. Liu, Y. Li and Z. Liu, Adv. Funct. Mater., 2014, 24, 6492-6502.\n73. X. Zhu, W. Lu, Y. Zhang, A. Reed, B. Newton, Z. Fan, H. Yu, P. C. Ray and R. Gao, Chem. Commun., 2011, 47, 10311-10313.\n74. B. R. Vummidi, F. Noreen, J. Alzeer, K. Moelling and N. W. Luedtke, ACS Chem. Biol., 2013, 8, 1737-1746.\n75. C.-S. Lee, W. Park, Y. U. Jo and K. Na, Chem. Commun., 2014, 50, 4354-4357.\n76. Y. Tao, R. Liu, M. Chen, C. Yang and X. Liu, J. Mater. Chem., 2012, 22, 373-380.\n77. W. Scarano, P. de Souza and M. H. Stenzel, Biomater. Sci., 2015, 3, 163-174.\n78. Y. Cheng, C. He, C. Xiao, J. Ding, K. Ren, S. Yu, X. Zhuang and X. Chen, Polym. Chem., 2013, 4, 3851-3858.\n79. R. F. Pasternack, P. R. Huber, P. Boyd, G. Engasser, L. Francesconi, E. Gibbs, P. Fasella, G. Cerio Venturo and L. d. Hinds, J. Am. Chem. Soc., 1972, 94, 4511-4517.\n80. K. Kano, M. Takei and S. Hashimoto, J. Phys. Chem., 1990, 94, 2181- 2187.\n81. K. M. Donahue, D. Burstein, W. J. Manning and M. L. Gray, Magn. Reson. Med., 1994, 32, 66-76.\n82. S. S. Kelkar, L. Xue, S. R. Turner and T. M. Reineke, Biomacromolecules, 2014, 15, 1612-1624.\n83. Z. Zhu, Z. Tang, J. A. Phillips, R. Yang, H. Wang and W. Tan, J. Am. Chem. Soc., 2008, 130, 10856-10857.\n84. S. P. Sherlock, S. M. Tabakman, L. Xie and H. Dai, ACS Nano, 2011, 5, 1505-1512.\n85. B. Tian, C. Wang, S. Zhang, L. Feng and Z. Liu, ACS Nano, 2011, 5, 7000-7009.\n86. Y.-K. Kim, H.-K. Na, S. Kim, H. Jang, S.-J. Chang and D.-H. Min, Small, 2015, 11, 2527-2535.\n87. L. V. Wang and S. Hu, Science, 2012, 335, 1458-1462.\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n2 8\nJu ly\n2 01\n6. D\now nl\noa de\nd by\nC or\nne ll\nU ni\nve rs\nity L\nib ra\nry o\nn 28\n/0 7/\n20 16\n1 1:\n26 :1\n9.\nView Article Online DOI: 10.1039/C6NR04835H"
    } ],
    "references" : [ {
      "title" : "and K",
      "author" : [ "H.-C. Yen", "H. Cabral", "P. Mi", "K. Toh", "Y. Matsumoto", "X. Liu", "H. Koori", "A. Kim", "K. Miyazaki", "Y. Miura", "N. Nishiyam" ],
      "venue" : "Kataoka, ACS Nano,",
      "citeRegEx" : "1",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "R",
      "author" : [ "Y. Shi" ],
      "venue" : "van der Meel, B. Theek, E. Oude Blenke, E. H. E. Pieters, M. H. A. M. Fens, J. Ehling, R. M. Schiffelers, G. Storm, C. F. van Nostrum, T. Lammers and W. E. Hennink, ACS Nano,",
      "citeRegEx" : "2",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "P",
      "author" : [ "V.T. Huynh", "S. Binauld" ],
      "venue" : "L. de Souza and M. H. Stenzel, Chem. Mater.,",
      "citeRegEx" : "3",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Chem",
      "author" : [ "N. Kamaly", "B. Yameen", "J. Wu", "O.C. Farokhzad" ],
      "venue" : "Rev.,",
      "citeRegEx" : "4",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "Chem",
      "author" : [ "M. Elsabahy", "G.S. Heo", "S.-M. Lim", "G. Sun", "K.L. Wooley" ],
      "venue" : "Rev.,",
      "citeRegEx" : "5",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "and D",
      "author" : [ "Y. Huang", "R. Dong", "X. Zh" ],
      "venue" : "Yan, Soft Matter,",
      "citeRegEx" : "6",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "and X",
      "author" : [ "X. Liu", "B. Chen", "X. Li", "L. Zhang", "Y. Xu", "Z. Liu", "Z. Chen" ],
      "venue" : "Zhu, Nanoscale,",
      "citeRegEx" : "7",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Adv",
      "author" : [ "Y. Zhao", "F. Sakai", "L. Su", "Y. Liu", "K. Wei", "G. Chen", "M. Jiang" ],
      "venue" : "Mater.,",
      "citeRegEx" : "8",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "H",
      "author" : [ "P. Yan", "R. Wang", "N. Zhao" ],
      "venue" : "Zhao, D.-F. Chen and F.-J. Xu, Nanoscale,",
      "citeRegEx" : "9",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Adv",
      "author" : [ "N.R. Patel", "B.S. Pattni", "A.H. Abouzeid", "V.P. Torchilin" ],
      "venue" : "Drug Deliver. Rev.,",
      "citeRegEx" : "10",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Nat",
      "author" : [ "V.P. Torchilin" ],
      "venue" : "Rev. Drug Discov.,",
      "citeRegEx" : "11",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Chem",
      "author" : [ "Z. Ge", "S. Liu" ],
      "venue" : "Soc. Rev.,",
      "citeRegEx" : "12",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Chem",
      "author" : [ "X. Liu", "Q. Chen", "G. Yang", "L. Zhang", "Z. Liu", "Z. Cheng", "X. Zhu", "J. Mater" ],
      "venue" : "B,",
      "citeRegEx" : "13",
      "shortCiteRegEx" : null,
      "year" : 2015
    } ],
    "referenceMentions" : [ ],
    "year" : 2016,
    "abstractText" : "Please note that technical editing may introduce minor changes to the text and/or graphics, which may alter content. The journal’s standard Terms & Conditions and the Ethical guidelines still apply. In no event shall the Royal Society of Chemistry be held responsible for any errors or omissions in this Accepted Manuscript or any consequences arising from the use of any information it contains. Accepted Manuscript Nanoscale",
    "creator" : "Aspose Ltd."
  }
}